AI
SAGE

Atria Investments’s Sage Therapeutics SAGE Stock Holding History

Atria Investments’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,594
Closed -$218K – 720
2020
Q1 		$218K Buy
7,594
+4,739
+166% +$274K 0.02% 513
2019
Q4 		$206K Buy
2,855
+759
+36% +$93.4K 0.01% 1142
2019
Q3 		$294K Buy
2,096
+71
+4% +$11.9K 0.01% 721
2019
Q2 		$331K Sell
2,025
-14
-0.7% -$2.39K 0.01% 712
2019
Q1 		$324K Sell
2,039
-173
-8% -$25.1K 0.01% 670
2018
Q4 		$212K Buy
2,212
+677
+44% +$77.5K 0.01% 797
2018
Q3 		$217K Buy
1,535
+141
+10% +$21.8K 0.01% 898
2018
Q2 		$218K Buy
+1,394
New +$219K 0.01% 871

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return